4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
PLoS Pathog
; 16(10): e1008882, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-33007046
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bacterial Proteins
/
Meningococcal Vaccines
/
Meningitis, Meningococcal
/
Antibodies
/
Antigens, Bacterial
/
Neisseria meningitidis
Type of study:
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
PLoS Pathog
Year:
2020
Type:
Article
Affiliation country:
Italy